Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC)

Dr. Stover's trial builds on the Phase 1a clinical data and the preclinical results, generated by Dialectic and Harvard School of Public Health, which demonstrate complete tumor eradication in both in ...
The Kingston Whig-Standard

New Report Released by Dialectic Shows How to Design Workplace Training That Withstands DEI Backlash

November 3, 2025) – Amid political backlash against Diversity, Equity, and Inclusion (DEI) initiatives, many organizations are rethinking how to deliver training that both works and withstands ...